Cargando…
Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia
The current study aimed to evaluate the effectiveness of peripheral blood mononuclear cell (PB-MNC) therapy as adjuvant treatment for patients with diabetic foot ulcers (DFUs) and no-option critical limb ischaemia (NO-CLI). The study is a prospective, noncontrolled, observational study including pat...
Autores principales: | Meloni, Marco, Giurato, Laura, Andreadi, Aikaterini, Bellizzi, Ermanno, Bellia, Alfonso, Lauro, Davide, Uccioli, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573900/ https://www.ncbi.nlm.nih.gov/pubmed/37834766 http://dx.doi.org/10.3390/jcm12196123 |
Ejemplares similares
-
Geographic and Ethnic Inequalities in Diabetes-Related Amputations
por: Bellia, Alfonso, et al.
Publicado: (2022) -
The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy
por: Meloni, Marco, et al.
Publicado: (2022) -
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
por: Panunzi, Andrea, et al.
Publicado: (2022) -
Characteristics and Outcome for Persons with Diabetic Foot Ulcer and No-Option Critical Limb Ischemia
por: Meloni, Marco, et al.
Publicado: (2020) -
Activation of Peripheral Blood Mononuclear Cells and Leptin Secretion: New Potential Role of Interleukin-2 and High Mobility Group Box (HMGB)1
por: Coppola, Andrea, et al.
Publicado: (2021)